ICW Makes a Substantial Strategic Commitment to Focus on the U.S. Market

InterComponentWareInterComponentWare AG (ICW), an international eHealth company headquartered in Walldorf, Germany, has invested substantially over the last two years to strongly focus on the current and future needs of the U.S. healthcare market, especially in the areas of Care Coordination and Care Management. Based on its mature, best-of-breed Health Information Exchange (HIE) and Master Patient Index (MPI) solutions, ICW has developed care management applications supporting care pathways across all venues, as well as applications for collaborative care coordination. Due to its considerable progress, ICW has decided to reopen their operations in the U.S with teams in business development, sales and product management. ICW Inc. is headquartered in Bala Cynwyd, PA, includes key representatives in the Northeast and Silicon Valley, and is led by board members Peter J. Kirschbauer (Chairman & CEO), Nils Effertz (Chief Business Development Officer & COO) and Matthias Glück (Chief Financial Officer), along with top U.S. industry advisors.

"The U.S. Health Information Technology (HIT) market has made tremendous progress over the past years and its dynamics provide excellent opportunities for us. We're excited about supporting critical progress in underlying technologies, a plethora of care delivery applications, and multiple stakeholder collaborations within a U.S. healthcare system that is increasingly shifting from fee-for-service to fee-for-value. Our go-to-market strategy will be centered around key strategic partnerships, which, as part of sustainably growing our U.S. organization, we'll complement with select direct initiatives to work closely with our valued U.S. customers in order to meet their needs and gather best practices for IT adoption in healthcare ," says Nils Effertz.

ICW delivers solutions ideally suited for risk bearing healthcare organizations such as Accountable Care Organizations (ACO), as well as Integrated Delivery Networks (IDN), Health Systems and HIE focused organizations. ICW's products are offered both via one-time and subscription-based licensing, benefiting from 15 years of strong HIT software development expertise from its Germany-based parent company, ICW AG.

"This is a great time to partner and work with ICW. We're convinced that ICW is at the beginning of a U.S. growth cycle and we’ll be 100% focused on helping our partners and clients succeed in adopting HIT that is fully aligned with their strategic goals and gets us closer to achieving the triple aim of healthcare: better care, lower costs and improved outcomes. ICW's full commitment to the U.S. is fostered by our strong belief that a majority of our revenue will come from the U.S. market over the next years," states Peter J. Kirschbauer.

Related news articles:

About InterComponentWare AG
We are a privately owned international software company with over 15 years of experience in the field of Healthcare IT. We are headquartered in Walldorf, Germany, have our own subsidiary in the U.S. and are strongly U.S. market focused. We build efficient and reliable solutions to improve the quality and efficiency of care across the entire care continuum. Our solutions enable healthcare organizations to leverage innovative models for cross-enterprise care coordination and patient-centric care delivery. We apply state-of-the-art software technology to develop robust and highly scalable applications with a strong focus on optimal user experience. We support the most advanced communication and interoperability standards by design, and turn seamless integration into a straightforward process. Together with our partners, we deliver safe and sustainable solutions for more than 20 million patients across the United States, Germany and Switzerland.

Most Popular Now

AI Tool Helps Predict Relapse of Pediatr…

Artificial intelligence (AI) shows tremendous promise for analyzing vast medical imaging datasets and identifying patterns that may be missed by human observers. AI-assisted interpretation of brain scans may help improve...

Infectious Disease Surveillance Platform…

The Biothreats Emergence, Analysis and Communications Network (BEACON) leverages advanced artificial intelligence (AI), large language models (LLMs) and a network of globally based experts to rapidly collect, analyze, and disseminate...

NHS, Councils, and Housing could Share N…

A new technology partnership formally announced, could help NHS, local government, and housing organisations collaborate to create an unprecedented understanding of the risks and needs of people in their care...

Children's Health Ireland to Transf…

Healthcare teams responsible for paediatric care in Ireland are to save significant time in accessing important diagnostic imaging and reports, with the help of a new agreement with medical imaging...

AI-Powered Analysis of Stent Healing

Each year, more than three million people worldwide are treated with stents to open blocked blood vessels caused by heart disease. However, monitoring the healing process after implantation remains a...

Right Patient, Right Dose, Right Time

While artificial intelligence (AI) has shown promising potential, much of its use has remained theoretical or retrospective. Turning its potential into real-world healthcare outcomes, researchers at the Yong Loo Lin...

AXREM and BHTA Name Highland as 'Fu…

Hosted by trade associations AXREM and the British Healthcare Trades Association (BHTA), 'The Future of MedTech - Innovating for Tomorrow', will allow delegates to engage with speakers from the government...

Building Trust in Artificial Intelligenc…

A new review, published in the peer-reviewed journal AI in Precision Oncology, explores the multifaceted reasons behind the skepticism surrounding artificial intelligence (AI) technologies in healthcare and advocates for approaches...

AI could Help Improve Early Detection of…

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center suggests that artificial intelligence (AI) could help detect interval breast cancers - those that develop between...

Generative AI on Track to Shape the Futu…

Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In a new paper, Xia Ning, lead author of the study and...

Call for Papers: AI Applications in Biom…

JMIR Biomedical Engineering is inviting submissions for a new section titled "AI Applications in Biomedical Engineering." This themed section explores the integration of biomedical engineering and artificial intelligence (AI), focusing...

Siemens Healthineers infection Control S…

Klinikum Region Hannover (KRH) has commissioned Siemens Healthineers to install infection control system (ICS) at the Klinikum Siloah hospital. The ICS aims to effectively tackle nosocomial infections and increase patient...